EUR 115.88 For Business Accounts Only

Capricor Therapeutics Inc (CAPR) - Financial Analysis Review

Summary

Capricor Therapeutics Inc (CAPR) - Financial Analysis Review

Summary

Capricor Therapeutics Inc (Capricor) is a clinical-stage biotechnology company that discovers, develops and commercializes therapeutics for cardiac and various diseases. It offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced heart failure and duchenne muscular dystrophy associated cardiomyopathy. The company's lead product CAP- 1002, is in phase II clinical statge for the treatment of adult cardiology indications.

GlobalData's Capricor Therapeutics Inc (CAPR) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Capricor Therapeutics Inc Key Recent Developments:

Mar 15,2017: Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Nov 10,2016: Capricor Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Aug 15,2016: Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update
Jun 16,2016: Clinical Trial to Repair Damaged Heart Muscle With Cardiac Stem Cells Currently Underway at Lenox Hill Hospital
May 12,2016: Capricor Therapeutics Provides Corporate Update and Reports First Quarter 2016 Financial Results


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.